CBS and cancer: Clinical studies (available at: https://www.cannabis-med.org/studies/study.php) monitoring the effects of CBs in patients with different late stages of cancer given a cannabinoid spray (Sativex® containing THC and CBD at a ratio of 27:25 mg/mL) showed that this preparation is well tolerated and brought pain relief for ≤60% of patients suffering severe pain.